key: cord-0722111-n7x3uzjr authors: Uranaka, Tsukasa; Kashio, Akinori; Ueha, Rumi; Sato, Taku; Bing, Han; Ying, Gao; Kinoshita, Makoto; Kondo, Kenji; Yamasoba, Tatsuya title: Expression of Ace2, Tmprss2, and Furin in mouse ear tissue date: 2020-06-23 journal: bioRxiv DOI: 10.1101/2020.06.23.164335 sha: b5aceb76dd263feba8f9b9878d8c95ecb882e0db doc_id: 722111 cord_uid: n7x3uzjr Objectives Intracellular entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) depends on the interaction between its spike protein to a cellular receptor named angiotensin-converting enzyme 2 (ACE2) and depends on Furin-mediated spike 23 protein cleavage and spike protein priming by host cell proteases including 24 transmembrane protease serine 2 (TMPRSS2). Tmprss1, Tmprss3, and Tmprss5 are expressed in the spiral ganglion neurons and the organ of Corti in the inner ear; however, Ace2, Tmprss2, and Furin expression profiles in the middle ear remain unclear. Therefore, this study aimed to analyze Ace2, Tmprss2, and Furin expression in the middle and inner ear of mice. Study Design Animal research. Setting Department of Otolaryngology and Head and Neck Surgery, University of Tokyo. Methods We performed immunohistochemical analysis to examine the distribution of Ace2, Tmprss2, and Furin in the eustachian tube, middle ear space, and cochlea of mice. Results Ace2 was expressed in the cytoplasm in the middle ear epithelium, eustachian tube epithelium, stria vascularis, and spiral ganglion. Tmprss2 and Furin were widely expressed in the middle ear spaces and the cochlea. Conclusion Co-expression of Ace2, Tmprss2, and Furin in the middle ear indicates that the middle ear is susceptible to SARS-CoV-2 infections, thus warranting the use of personal protective equipment during mastoidectomy for coronavirus disease (COVID-19) patients. The recent coronavirus disease (COVID-19) pandemic caused by severe acute 55 respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious health concerns. 56 SARS-CoV-2 generally infects the upper respiratory tract and then spreads to various 57 organs. The clinical symptoms of COVID-19 patients include fever, cough, sore throat, 58 fatigue, and loss or decline of smell (anosmia or hyposmia). [1] [2] [3] [4] The Eustachian tube is 59 the conduit between the middle ear space and upper respiratory tract through which, 60 SARS-CoV-2 can spread into the middle ear spaces. Moreover, other human 61 coronaviruses have been identified in middle ear fluid in cases of acute otitis media or 62 otitis media with effusion. [5] [6] [7] Two studies have reported the occurrence of acute otitis 63 media 8 and sensorineural hearing loss 9 among COVID-19 patients. Another study 64 carried out pure tone audiometry and transitory evoked otoacoustic emission (TEOAE) 65 analysis for 20 asymptomatic patients aged 20-50 years positive for COVID-19 on 66 reverse transcription-PCR (RT-PCR) testing and reported that high-frequency pure-tone 67 thresholds and TEOAE amplitudes were significantly worse among the COVID-19 68 patients than among 20 healthy controls. 10 69 Intracellular entry of SARS-CoV-2 depends on the interaction between viral spike 70 proteins and a cellular receptor, angiotensin-converting enzyme 2 (Ace2) 11-13 , 71 Furin-mediated Spike cleavage 13-15 , and Spike protein priming by host cell proteases 72 including transmembrane protease serine 2 (Tmprss2). 13,16 Thus, Ace2, Tmprss2, and 73 Tmprss2 and Furin were expressed in the mucosal epithelial cells in the 118 middle ear spaces; however, Ace2 was only slightly expressed in the cytoplasm of the 119 epithelial cells (Fig.1A) . Furthermore, Ace2 and Tmprss2 were expressed in the nuclei 120 of epithelial cells. Ace2, Tmprss2, and Furin expression profiles in the Eustachian tube 121 were almost identical to those in the middle ear spaces (Fig.1B) . We would like to thank Editage (www.editage.com) for English language editing. 177 Clinical features of patients infected with 2019 novel 180 coronavirus in Wuhan, China Epidemiology and Clinical Characteristics of 182 COVID-19 Olfactory and gustatory 184 dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus 185 disease (COVID-19): a multicenter European study Objective evaluation of anosmia and ageusia in 188 COVID-19 patients: Single-center experience on 72 cases Detection of rhinovirus, respiratory syncytial 191 virus, and coronavirus infections in acute otitis media by reverse transcriptase 192 polymerase chain reaction Acute otitis media and respiratory viruses Polymerase chain reaction-based detection of 196 rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion New type of corona virus induced acute otitis media in adult Hearing loss and COVID-19: A note Audiological profile of asymptomatic Covid-19 PCR-positive cases 203 Angiotensin-converting enzyme 2 is a 205 functional receptor for the SARS coronavirus A new coronavirus associated with human respiratory 207 disease in China SARS-CoV-2 receptor ACE2 and TMPRSS2 210 are primarily expressed in bronchial transient secretory cells Function, and Antigenicity of the 213 SARS-CoV-2 Spike Glycoprotein The spike glycoprotein of the new 215 coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same 216 clade Enhanced isolation of SARS-CoV-2 by 218 TMPRSS2-expressing cells An integrated genetic and functional analysis of 220 14 the role of type II transmembrane serine proteases (TMPRSSs) in hearing loss Background mechanisms of olfactory 223 dysfunction in COVID-19: expression of ACE2, TMPRSS2, and Furin in the nose and 224 Demonstration and mitigation of aerosol 227 and particle dispersion during mastoidectomy relevant to the COVID-19 era Cadaveric Simulation of Otologic Procedures An Analysis of Droplet Splatter Patterns During the COVID-19 Pandemic Does coronavirus affect the audio-vestibular 235 system? A rapid systematic review